H.R. 4449 · 118th Congress
Pharmaceutical Security Production Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 118th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
TorresSponsor2 cosponsors · 2 R
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill establishes the Commission on Strengthening the Domestic Pharmaceutical Supply Chain.
What it does: CRS summary · Introduced in House · Jun 30, 2023
Pharmaceutical Security Production Act
This bill establishes the Commission on Strengthening the Domestic Pharmaceutical Supply Chain.
The commission must assess the security and vulnerabilities of the domestic pharmaceutical supply chain in the United States and recommend improvements, including by developing metrics for domestic manufacturing programs, proposing solutions to strengthen the domestic manufacturing workforce, and evaluating ways to support a financial market for domestically manufactured products.
The commission terminates four years after the bill is enacted.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Pharmaceutical Security Production Act
Latest action (Jul 7, 2023): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jun 30, 2023
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.